No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

BD Announces BD Kiestra ReadA is Now Available to U.S. Clinical Microbiology Laboratories

BD Kiestra™ ReadA, Available as a Standalone Instrument, Helps Improve Operational Efficiency in Clinical Microbiology Laboratories by Automating Routine Plate Management Tasks and Delivers Accuracy Through Standardized Digital Image Acquisition

Editor: What To Know

  • The BD Kiestra™ ReadA instrument is a first-to-market solution that will enable new customers to enter microbiology lab automation at the incubation and imaging step,” said Steve Conly, vice president of microbiology at BD.
  • “Building on the landmark CE marking of BD Kiestra™ IdentifA in November, we continue to execute on our strategy of modular laboratory automation solutions.
  • The BD Kiestra ReadA provides closed door incubation and high throughput imaging to streamline workflow, delivering high quality images for digital interpretation by laboratory staff.

The BD Kiestra ReadA provides closed door incubation and high throughput imaging to streamline workflow, delivering high quality images for digital interpretation by laboratory staff.

By reducing the time spent sorting plates combined with high resolution imaging, the system helps enhance operational efficiency and may reduce time to result.

“Building on the landmark CE marking of BD Kiestra IdentifA in November, we continue to execute on our strategy of modular laboratory automation solutions. The BD Kiestra ReadA instrument is a first-to-market solution that will enable new customers to enter microbiology lab automation at the incubation and imaging step,” said Steve Conly, vice president of microbiology at BD. “The system transforms the manual, hands-on workflow of plate-reading to one that is automated and digital.”

Powered by BD Synapsys microbiology informatics solution, the BD Kiestra ReadA also provides on-demand patient summary overviews, allowing lab staff to access actionable information from anywhere, any time.

BD continues to invest in automation and innovation for the microbiology laboratory. For more information on BD Kiestra lab automation solutions, please visit https://www.bd.com/en-us/offerings/capabilities/lab-automation.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy